Equities Research Analysts’ New Coverage for September 29th (ABCL, ADPT, AEE, AESI, APYX, EMPD, FCEL, HNGE, HYLN, LBRT)
Equities Research Analysts’ new coverage for Tuesday, September 29th: JPMorgan Chase & Co. started coverage on shares of AbCellera Biologics (NASDAQ:ABCL). JPMorgan Chase & Co. issued an overweight rating and a $17.00 price target on the stock. The Goldman Sachs Group, Inc. started coverage on shares of Adaptive Biotechnologies (NASDAQ:ADPT). They issued a buy rating […]
29 Sep 17:44 · The Markets Daily